Heron Therapeutics, Inc. · NASDAQ:HRTX

Forbes William P exercised options for 3,874 Heron Therapeutics, Inc. shares (Form 4)

Traded Apr 19, 2026 · Filed Apr 21, 2026

On Apr 19, 2026, Forbes William P (EVP, Chief Development Officer) exercised options for 3,874 Heron Therapeutics, Inc. shares, leaving 185,647 shares. Filed Apr 21, 2026 (Form 4).

Options exercised
3,874 shares
Holding after
185,647 shares
Trading plan
No
Role
EVP, Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 19, 2026Common StockOption exercise3,874185,647Direct

Source

View original at SEC

Related